Onconetix issues $117k promissory note, changes auditor, strategy officer resigns

Onconetix, Inc.

Entered $117,647 promissory note with Keystone Capital; purchase price $100k, due Nov 12, 2025 or earlier from ELOC proceeds.
Appointed MaloneBailey LLP as new independent auditor effective Feb 13, 2025; no prior disagreements or reportable events.
Christian Brühlmann resigned as Chief Strategy Officer on Feb 18, 2025; remains as Chief Business Officer of Proteomedix AG.
Note is subordinate to existing Veru Inc debt obligations.

item 1.01 item 2.03 item 4.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christian Brühlmann

Chief Strategy Officer

ONCO · Onconetix, Inc.

Effective: 2025-02-18
Filed: February 18, 2025, 6:59 PM ET

On February 18, 2025, Christian Brühlmann resigned from his position as Chief Strategy Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christian Brühlmann resigned as Chief Strategy Officer at Onconetix, Inc..

Action: resigned
Role: Chief Strategy Officer

Exact text from the filing

On February 18, 2025, Christian Brühlmann resigned from his position as Chief Strategy Officer of the Company.

View on SEC.gov

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-014928

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.